UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023707
Receipt number R000027300
Scientific Title The Effects of Intravenous Anesthetics on QT interval during Anesthetic Induction with Desflurane
Date of disclosure of the study information 2016/08/22
Last modified on 2018/03/16 17:34:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The Effects of Intravenous Anesthetics on QT interval during Anesthetic Induction with Desflurane

Acronym

The Effects of Intravenous Anesthetics on QT interval during Anesthetic Induction with Desflurane

Scientific Title

The Effects of Intravenous Anesthetics on QT interval during Anesthetic Induction with Desflurane

Scientific Title:Acronym

The Effects of Intravenous Anesthetics on QT interval during Anesthetic Induction with Desflurane

Region

Japan


Condition

Condition

The patients who undergo lumbar surgery

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is the effects of intravenous anesthetics(propofol or thiamylal) on QT interval during anesthetic induction with Desflurane

Basic objectives2

Pharmacodynamics

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

QT interval time from pre-induction to after intubation

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Patients receive fentanyl 3ug/kg and after 2 min, 1.5mg/kg propofol . Rocuronium(0.6mg/kg) and Desflurane (3% inhaled concentration,increasing 1% every 4 ventilation for 6%) are administrated immediately after loss of consciousness. Tracheal intubation is perfomed 3 min after Rocuronium injection. Heart rate(HR),mean artrial pressure(MAP),bispectral index score(BIS),and the heart rate corrected QT(QTc) interval on 12-lead electrocardiogram are recorded immediately before fentanyl administration(T1),2min after fentanyl injection(T2),1 min after propofol injection(T3),3min after Desflurane administration(T4), and 2min after intubation(T5).

Interventions/Control_2

Patients receive fentanyl 3ug/kg and after 2 min, 5mg/kg thiamylal. Rocuronium(0.6mg/kg) and Desflurane (3% inhaled concentration,increasing 1% every 4 ventilation for 6%) are administrated immediately after loss of consciousness. Tracheal intubation is perfomed 3 min after Rocuronium injection. Heart rate(HR),mean artrial pressure(MAP),bispectral index score(BIS),and the heart rate corrected QT(QTc) interval on 12-lead electrocardiogram are recorded immediately before fentanyl administration(T1),2min after fentanyl injection(T2),1 min after thiamylal injection(T3),3min after Desflurane administration(T4), and 2min after intubation(T5).

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

The patients who undergo lumbar spine surgery with ASA risk 1 or 2

Key exclusion criteria

1.heart disease
2.arrhythmia
3.antiarrhythmia drug
4.antipsychotic drug
5.hypo/hyper kalemia(<3.5mEq/L,
>5.5mEq/L)
6.asthma
7.BMI>30

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshiaki Terao

Organization

Nagasaki Rosai Hospital

Division name

Department of anesthesia

Zip code


Address

2-12-5,setogoe,sasebo,Nagasaki,Japan

TEL

0956-49-2191

Email

yoterao@na-robyo.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shozo Tominaga

Organization

Nagasaki Rosai Hospital

Division name

Department of anesthesia

Zip code


Address

2-12-5,setogoe,sasebo,Nagasaki,Japan

TEL

0956-49-2191

Homepage URL


Email

tommy1121elephant@gmail.com


Sponsor or person

Institute

Nagasaki Rosai Hospital Medical Office

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 08 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

Fifty-three patients, 38male and 15female, were enrolled in the study. Of these, 3 patients (2 male, 1 from each group, and 1 female from Group T were excluded because their ECG data were wrongly entered in the software. Therefore, 50 patients were included in the final analysis.There were no significant differences between the 2 groups.
There were no significant differences in ETdes between the 2 groups. BIS and MAP were significantly decreased after anesthesia induction in both groups. MAP in Propofol group was lower than Thiamylal group after anesthesia induction. There were no significant differences in HR and QTcD at any recorded time point.
In Group P, the QTc interval values at T3 was significantly shortened compared with the QTc interval at T1. In Group T, the QTc interval values at T4 and T5 were significantly prolonged compared with the QTc interval at T1. The QTc intervals at T3, T4 and T5 in Group T were significantly longer than those in Group P.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 06 Month 27 Day

Date of IRB


Anticipated trial start date

2016 Year 08 Month 22 Day

Last follow-up date

2017 Year 06 Month 30 Day

Date of closure to data entry

2017 Year 09 Month 18 Day

Date trial data considered complete

2017 Year 09 Month 18 Day

Date analysis concluded

2017 Year 10 Month 20 Day


Other

Other related information



Management information

Registered date

2016 Year 08 Month 21 Day

Last modified on

2018 Year 03 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027300


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name